ultrafiltration

超滤
  • 文章类型: Journal Article
    近年来,在蛋白质纯化和质量控制(QC)方面,新技术和策略的发展迅速,但是这些过程的基本技术可以追溯到很久以前,在过去的几十年里有很多改进。本章的目的是回顾这些方法,以及其他一些主题,例如细胞内或细胞外蛋白质的各种纯化方法的优缺点,最有效和广泛使用的基因工程亲和标签,溶解度增强标签,和用于去除非靶序列的特异性蛋白酶。亲和层析(AC),如用于回收抗体或Fc融合蛋白的蛋白A或G树脂或用于回收组氨酸标记蛋白的固定化金属,将与其他常规色谱技术一起讨论:离子交换(IEC),疏水交换(HEC),混合模式(MMC),尺寸排除(SEC),和超滤(UF)系统。如何选择和结合这些不同的技术来纯化任何给定的蛋白质,以及对纯度进行QC表征的最低标准,同质性,身份,和完整性的最终产品将呈现。
    In the recent years, there has been a rapid development of new technologies and strategies when it comes to protein purification and quality control (QC), but the basic technologies for these processes go back a long way, with many improvements over the past few decades. The purpose of this chapter is to review these approaches, as well as some other topics such as the advantages and disadvantages of various purification methods for intracellular or extracellular proteins, the most effective and widely used genetically engineered affinity tags, solubility-enhancing tags, and specific proteases for removal of nontarget sequences. Affinity chromatography (AC), like Protein A or G resins for the recovery of antibodies or Fc fusion proteins or immobilized metals for the recovery of histidine-tagged proteins, will be discussed along with other conventional chromatography techniques: ion exchange (IEC), hydrophobic exchange (HEC), mixed mode (MMC), size exclusion (SEC), and ultrafiltration (UF) systems. How to select and combine these different technologies for the purification of any given protein and the minimal criteria for QC characterization of the purity, homogeneity, identity, and integrity of the final product will be presented.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    使用1992年至2021年的科学引文索引扩展数据库进行了文献计量研究,以确定哪些是纺织废水处理研究的当前趋势。该研究旨在分析学术科学传播在年度出版物/引文方面的表现,总引用次数,科学期刊,以及它们在WebofSciences中的分类,顶级机构/国家和研究趋势。科学文章的年度出版在前十年波动,在过去的二十年里稳步下降。对作者关键词中最常用术语的分析,出版物标题,和KeyWordsPlus进行了预测未来的趋势和当前的研究重点。吸附剂纳米材料将是废水处理的未来,用于脱色废水中残留的染料。膜和电解对于使纺织废水脱矿质以再利用废水很重要。现代过滤技术如超滤和纳滤是先进的膜过滤应用。
    A bibliometric study using 1992 to 2021 database of the Science Citation Index Expanded was carried out to identify which are the current trends in textile wastewater treatment research. The study aimed to analyze the performance of scholarly scientific communications in terms of yearly publications/citations, total citations, scientific journals, and their categories in the Web of Sciences, top institutions/countries and research trends. The annual publication of scientific articles fluctuated in the first ten years, with a steady decrease for the last twenty years. An analysis of the most common terms used in the authors\' keywords, publications\' titles, and KeyWords Plus was carried out to predict future trends and current research priorities. Adsorbent nanomaterials would be the future of wastewater treatment for decoloration of the residual dyes in the wastewater. Membranes and electrolysis are important to demineralize textile effluent for reusing wastewater. Modern filtration techniques such as ultrafiltration and nanofiltration are advanced membrane filtration applications.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    铀是一种天然存在于地壳中的放射性元素。它具有亲石特性,表明它倾向于位于地球表面附近并与氧气紧密结合。它是生态毒性的,因此需要将其从水性环境中去除。本文重点介绍了从水中去除铀的各种水处理工艺,其中包括物理(膜分离,吸附和电凝),化学(离子交换,光催化和过硫酸盐还原),和生物(生物还原和生物吸附)方法。观察到膜过滤和离子交换是该应用中最流行和最有前途的方法。膜工艺具有高通量,但具有高功率要求和结垢的挑战。除了高pH敏感性,离子交换没有任何重大的挑战相关的应用。从这篇综述中得出了其他一些独特的观察结果。含磷酸配体的壳聚糖/蛋白核小球藻复合吸附剂,羟基磷灰石气凝胶和MXene/氧化石墨烯复合材料对铀显示出超吸附性能(>1000mg/g吸收能力)。超滤(UF)膜,对于文献中报道的大多数情况,已观察到反渗透(RO)膜和电凝聚不低于97%的铀去除/转化效率。最近已经对热过硫酸盐还原进行了探索,并显示出达到高达86%的铀还原效率。我们预计未来的研究将探索混合工艺(多种常规技术的任意组合),以解决工艺设计和性能挑战的各个方面。
    Uranium is a naturally existing radioactive element present in the Earth\'s crust. It exhibits lithophilic characteristics, indicating its tendency to be located near the surface of the Earth and tightly bound to oxygen. It is ecotoxic, hence the need for its removal from the aqueous environment. This paper focuses on the variety of water treatment processes for the removal of uranium from water and this includes physical (membrane separation, adsorption and electrocoagulation), chemical (ion exchange, photocatalysis and persulfate reduction), and biological (bio-reduction and biosorption) approaches. It was observed that membrane filtration and ion exchange are the most popular and promising processes for this application. Membrane processes have high throughput but with the challenge of high power requirements and fouling. Besides high pH sensitivity, ion exchange does not have any major challenges related to its application. Several other unique observations were derived from this review. Chitosan/Chlorella pyrenoidosa composite adsorbent bearing phosphate ligand, hydroxyapatite aerogel and MXene/graphene oxide composite has shown super-adsorbent performance (>1000 mg/g uptake capacity) for uranium. Ultrafiltration (UF) membranes, reverse osmosis (RO) membranes and electrocoagulation have been observed not to go below 97% uranium removal/conversion efficiency for most cases reported in the literature. Heat persulfate reduction has been explored quite recently and shown to achieve as high as 86% uranium reduction efficiency. We anticipate that future studies would explore hybrid processes (which are any combinations of multiple conventional techniques) to solve various aspects of the process design and performance challenges.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    这篇综述论文介绍了这种疾病几个世纪以来的演变,描述和总结了病理生理机制,简要讨论利尿剂的作用机制,展示了它们在减轻患者充血心力衰竭中的作用,并揭示了超滤在急性或慢性失代偿性心力衰竭(ADHF)管理中的数据,专注于该领域的所有可用数据和进步。急性失代偿性心力衰竭(ADHF)是一种关键的临床疾病,其特征是心力衰竭的症状和体征恶化。需要及时干预以减轻充血和改善心功能。利尿剂传统上是管理ADHF中流体过载的主要方法。越来越多的证据表明,由于多种原因,如共存的肾功能衰竭或长期使用的loop利尿剂,人们注意到利尿剂抵抗率的上升,需要加以解决。已经有一系列试验将不同类别的利尿剂组合在一起,但没有预期的结果。新出现的证据表明,超滤可能提供一种替代或辅助方法。
    This review paper presents a review of the evolution of this disease throughout the centuries, describes and summarizes the pathophysiologic mechanisms, briefly discusses the mechanism of action of diuretics, presents their role in decongesting heart failure in patients, and reveals the data behind ultrafiltration in the management of acutely or chronically decompensated heart failure (ADHF), focusing on all the available data and advancements in this field. Acutely decompensated heart failure (ADHF) presents a critical clinical condition characterized by worsening symptoms and signs of heart failure, necessitating prompt intervention to alleviate congestion and improve cardiac function. Diuretics have traditionally been the mainstay for managing fluid overload in ADHF. Mounting evidence suggests that due to numerous causes, such as coexisting renal failure or chronic use of loop diuretics, an increasing rate of diuretic resistance is noticed and needs to be addressed. There has been a series of trials that combined diuretics of different categories without the expected results. Emerging evidence suggests that ultrafiltration may offer an alternative or adjunctive approach.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    第三间隔液体是失代偿期肝硬化住院患者的常见并发症。除了腹水,晚期肝硬化患者可能会出现明显的外周水肿,这可能会限制活动性,加剧虚弱和肌肉萎缩。合并的肾功能衰竭和心功能不全可能导致恶化的高血容量,最终可能导致肺水肿和呼吸受损。在这些患者中使用利尿剂可能受到肾功能障碍和电解质异常的限制,包括低钠血症和低钾血症。一个缓慢的,称为水分离的连续形式的超滤是一种体外流体去除方法,其中泵产生跨膜压力,迫使等渗超滤液穿过半透膜。这导致去除与血液等渗的超滤液,而不需要透析液或置换液,如在其他形式的连续肾脏替代疗法中所需的。该技术已用于其他疾病,包括急性失代偿性心力衰竭,试验显示混合,但总体上是有利的结果。在这里,我们提出了一系列我们自己的经验,在肝硬化患者中使用水分离术,回顾有关其在其他高血容量状态中使用的文献,并讨论我们如何将从使用水分离疗法治疗心力衰竭的经验教训应用于终末期肝病患者。
    Third-spacing of fluid is a common complication in hospitalized patients with decompensated cirrhosis. In addition to ascites, patients with advanced cirrhosis may develop significant peripheral edema, which may limit mobility and exacerbate debility and muscle wasting. Concomitant kidney failure and cardiac dysfunction may lead to worsening hypervolemia, which may ultimately result in pulmonary edema and respiratory compromise. Diuretic use in such patients may be limited by kidney dysfunction and electrolyte abnormalities, including hyponatremia and hypokalemia. A slow, continuous form of ultrafiltration known as aquapheresis is a method of extracorporeal fluid removal whereby a pump generates a transmembrane pressure that forces an isotonic ultrafiltrate across a semipermeable membrane. This leads to removal of an ultrafiltrate that is isotonic to blood without the need for dialysate or replacement fluid as is necessary in other forms of continuous kidney replacement therapy. This technique has been utilized in other conditions including acute decompensated heart failure, with trials showing mixed, but generally favorable results. Herein, we present a series of our own experience using aquapheresis among patients with cirrhosis, review the literature regarding its use in other hypervolemic states, and discuss how we may apply lessons learned from use of aquapheresis in heart failure to patients with end-stage liver disease.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    果汁是一种重要的食品,已经得到消费者的广泛认可。协调浓度,营养成分的保存,和果汁的热响应感觉是食品加工中要求很高的主题。膜分离是一种很有前途的技术,可以在最小的压力和温度下浓缩果汁,在食品工业中具有出色的潜在应用,稳定,和标准操作视图。由于对减压驱动膜的需求不断增加,微滤(MF)和超滤(UF)也对水果工业感兴趣。UF和MF膜广泛应用于浓缩,澄清,净化各种可食用产品。然而,膜技术中不断上升的挑战是污染倾向,它破坏了膜的性能和寿命。这篇综述简洁地提供了一个清晰而创新的观点,这些因素可能会破坏果汁澄清和浓缩过程中膜的选择性和渗透性。在这篇文章中,使用膜减轻果汁加工过程中结垢异常的各种策略,加上研究机会,已经讨论过了。这篇简明的评论预计将激发一个新的研究平台,用于开发下一代膜工艺的集成方法,以实现有效的果汁澄清。
    Fruit juice is an essential food product that has received significant acceptance among consumers. Harmonized concentration, preservation of nutritional constituents, and heat-responsive sensorial of fruit juices are demanding topics in food processing. Membrane separation is a promising technology to concentrate juice at minimal pressure and temperatures with excellent potential application in food industries from an economical, stable, and standard operation view. Microfiltration (MF) and ultrafiltration (UF) have also interested fruit industries owing to the increasing demand for reduced pressure-driven membranes. UF and MF membranes are widely applied in concentrating, clarifying, and purifying various edible products. However, the rising challenge in membrane technology is the fouling propensity which undermines the membrane\'s performance and lifespan. This review succinctly provides a clear and innovative view of the various controlling factors that could undermine the membrane performance during fruit juice clarification and concentration regarding its selectivity and permeance. In this article, various strategies for mitigating fouling anomalies during fruit juice processing using membranes, along with research opportunities, have been discussed. This concise review is anticipated to inspire a new research platform for developing an integrated approach for the next-generation membrane processes for efficient fruit juice clarification.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Meta-Analysis
    背景:失代偿性心力衰竭住院是一个主要的公共卫生问题。
    方法:我们进行了一项荟萃分析,以总结和分析在降低死亡率或再入院方面,使用超滤是否优于利尿剂。首先确定了10项随机对照试验(RCTs),包括941例患者。
    结果:与利尿剂相比,超滤治疗与心力衰竭住院率显着降低(风险比[RR]:0.72;95%置信区间[CI]:0.55-0.96,p=0.02)以及体重和净液体损失显着增加(平均差异[MD]:-1.55,CI:-2.36至-0.74,p=0.0002)和(MD:-2.10,CI:-3.32至-0.89,p=0.0007)分别。关于住院时间,治疗之间没有显着差异,血清肌酐水平升高,和死亡率。
    结论:在失代偿性心力衰竭患者中,与利尿剂相比,超滤与减少再住院和增加体重/净液体损失有关。
    BACKGROUND: Hospitalization for decompensated heart failure is a major public health issue.
    METHODS: We performed a meta-analysis to summarize and analyze if there is a benefit in using ultrafiltration over diuretics in terms of reducing mortality or hospital readmissions, primarily and identified 10 randomized controlled trials (RCTs) including 941 patients.
    RESULTS: Compared to diuretics, treatment with ultrafiltration was associated with a significant reduction in heart failure hospitalizations (risk ratio [RR]: 0.72; 95% confidence interval [CI]: 0.55-0.96, p = 0.02) and significant increase in weight and net fluid loss (mean difference [MD]: -1.55, CI: -2.36 to -0.74, p = 0.0002) and (MD: -2.10, CI: -3.32 to -0.89, p = 0.0007), respectively. There was no significant difference among treatments regarding the duration of hospitalization, the increase in serum creatinine levels, and mortality.
    CONCLUSIONS: Among patients with decompensated heart failure, compared to diuretics, ultrafiltration is associated with reduced rehospitalizations and increased weight/net fluid loss.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Review
    在传统的废水处理厂(WWTP)和饮用水处理厂(DWTP)中,微塑料(MP)不能完全从水/废水中去除。根据文献分析,膜技术,先进的处理技术之一,是从水和废水中去除MP的最有效和最有前途的技术。在本文中,首先,简要回顾了WWTP/DWTP中常见的MP的特性以及WWTP/DWTP的MP去除效率。此外,通过微滤(MF)从水/废水中去除MP的研究,超滤(UF),纳滤(NF),反渗透(RO),和膜生物反应器(MBR)进行了综述。在下一节中,将膜过滤与用于从水/废水中去除MP的其他方法进行比较,并讨论了去除方法的优缺点。此外,讨论了过滤过程中膜污染MP的问题以及MP从聚合物膜结构释放到水/废水中的可能性。最后,根据文献中的研究,指出了膜技术去除MP的现状和研究不足,并提出了进一步研究的建议。
    Microplastics (MPs) cannot be completely removed from water/wastewater in conventional wastewater treatment plants (WWTPs) and drinking water treatment plants (DWTPs). According to the literature analysis, membrane technologies, one of the advanced treatment technologies, are the most effective and promising technologies for MP removal from water and wastewater. In this paper, firstly, the properties of MPs commonly present in WWTPs/DWTPs and the MP removal efficiency of WWTPs/DWTPs are briefly reviewed. In addition, research studies on MP removal from water/wastewater by microfiltration (MF), ultrafiltration (UF), nanofiltration (NF), reverse osmosis (RO), and membrane bioreactors (MBRs) are reviewed. In the next section, membrane filtration is compared with other methods used for MP removal from water/wastewater, and the advantages/disadvantages of the removal methods are discussed. Moreover, the problem of membrane fouling with MPs during filtration and the potential for MP release from polymeric membrane structure to water/wastewater are discussed. Finally, based on the studies in the literature, the current status and research deficiencies of MP removal by membrane technologies are identified, and recommendations are made for further studies.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    超滤是消除急性失代偿性心力衰竭(HF)患者的液体潴留和充血而不影响循环量的有效方法。尽管与利尿剂相比,其疗效尚有争议,我们的分析评估是基于各种研究,包括已发表的关于超滤的临床试验,以及比较利尿剂和超滤疗效的研究。除此之外,我们还看提供上述程序的缺点及其未来进步的范围的文献。心力衰竭最终导致容量超负荷,这是一个高度令人担忧的并发症。利尿剂已被用作液体超负荷的一线治疗,但由于耐药性和肾功能障碍的发展而变得无效。超滤,另一方面,是一个有吸引力的替代计数器体积过载和拥塞,对药物治疗没有反应。也有证据表明,它显着降低了未来代偿失调发作的可能性。有,然而,关于超滤是否是改善这些患者死亡率的有效方法存在分歧。缺乏结论性研究证明一种流体去除方法优于另一种方法。因此,必须继续寻找最有效的方法来治疗拥堵。应优先考虑有关超滤的更多机理研究。
    Ultrafiltration is an effective method to get rid of fluid retention and congestion in patients with acute decompensated heart failure (HF) without affecting the circulating volume. Although its efficacy in comparison to diuretics is debatable, the evaluation of our analysis is based on various studies that comprise published clinical trials on ultrafiltration and studies comparing the efficacy of diuretics and ultrafiltration. Apart from this, we also look at literature that provides shortcomings of the said procedure and its scope for future advancements. Heart failure ultimately leads to volume overload, which is a highly concerning complication. Diuretics have been used as a first-line treatment for fluid overload but are becoming inefficacious due to the development of resistance and renal dysfunction. Ultrafiltration, on the other hand, is an attractive alternative to counter volume overload and congestion, which are unresponsive to medical therapy. There is also evidence that it significantly decreases the probability of future episodes of decompensation. There are, however, disagreements about whether ultrafiltration is an effective method to improve mortality in these patients. There is a lack of conclusive studies demonstrating the superiority of one fluid removal method over another. Hence, it is imperative to continue searching for the most effective method to treat congestion. Priority should be given to more mechanistic studies regarding ultrafiltration.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    在美国和欧洲,心力衰竭的住院治疗每年超过100万,90%以上是由于液体超负荷的症状和体征。无论是否以低剂量和高剂量或通过推注和连续输注给予loop利尿剂,60天的再住院或急诊就诊率都是显着的。超滤(UF)已被认为是一个有希望的替代阶梯式利尿剂治疗,它包括在机械,通过应用泵产生的静水压力梯度,可调节地去除半透膜上的等渗血浆水。用超滤去除流体具有若干优点,例如消除较高量的钠,而神经激素活化较少。然而,UF研究的相互矛盾的结果突出表明,患者选择和液体清除目标尚未完全了解.评估流体状态并因此建立流体去除目标的最佳方法也仍然是争论的问题。在这里,我们提供了关于超滤在液体超负荷患者中的作用及其在日常实践中的差距的最新系统综述.
    Hospitalizations for heart failure exceed 1 million per year in both the United States and Europe and more than 90% are due to symptoms and signs of fluid overload. Rates of rehospitalizations or emergency department visit at 60 days are remarkable regardless of whether loop diuretics were administered at low vs high doses or by bolus injection vs continuous infusion. Ultrafiltration (UF) has been considered a promising alternative to stepped diuretic therapy and it consists in the mechanical, adjustable removal of iso-tonic plasma water across a semipermeable membrane with the application of hydrostatic pressure gradient generated by a pump. Fluid removal with ultrafiltration presents several advantages such as elimination of higher amount of sodium with less neurohormonal activation. However, the conflicting results from UF studies highlight that patient selection and fluid removal targets are not completely understood. The best way to assess fluid status and therefore establish the fluid removal target is also still a matter of debate. Herein, we provide an up-to-date systematic review about the role of ultrafiltration among patients with fluid overload and its gaps in daily practice.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

公众号